AMANDA SPARKS-BUSHNELL: Open Payments
NPI 1780729996 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$60,847 in 177 payments from 16 companies in 2025. Trend: 2023 $2,268 · 2024 $2,499 · 2025 $60,847
Speaker / faculty: $40,620Travel & lodging: $9,392Debt forgiveness: $6,382Food & beverage: $4,012Consulting: $440
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 76 | $52,381 |
| Neuronetics, Inc. | 1 | $6,382 |
| Alkermes, Inc. | 18 | $398 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $241 |
| Neurocrine BioSciences, Inc. | 8 | $236 |
| Axsome Therapeutics, Inc. | 8 | $230 |
| Otsuka America Pharmaceutical, Inc. | 10 | $182 |
| ABBVIE INC. | 15 | $160 |
| Collegium Pharmaceutical, Inc. | 12 | $148 |
| Biogen, Inc. | 3 | $113 |
Products named: SPRAVATO, NEUROSTAR TMS THERAPY SYSTEM, CAPLYTA, INGREZZA, Auvelity, LYBALVI, REXULTI, ARISTADA.
Industry payments across TN — which companies pay providers there.
